ROLLA, Roberta
 Distribuzione geografica
Continente #
EU - Europa 3.876
NA - Nord America 3.494
AS - Asia 983
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 6
SA - Sud America 6
OC - Oceania 5
Totale 8.383
Nazione #
US - Stati Uniti d'America 3.462
IE - Irlanda 1.363
DE - Germania 696
SE - Svezia 570
UA - Ucraina 447
IT - Italia 437
CN - Cina 298
HK - Hong Kong 280
FI - Finlandia 209
SG - Singapore 169
IN - India 117
IR - Iran 57
VN - Vietnam 48
FR - Francia 36
GB - Regno Unito 34
CA - Canada 32
CZ - Repubblica Ceca 30
BE - Belgio 23
EU - Europa 13
TR - Turchia 13
NL - Olanda 9
BR - Brasile 6
PL - Polonia 6
NG - Nigeria 5
AU - Australia 4
CH - Svizzera 4
RO - Romania 3
ES - Italia 2
LI - Liechtenstein 2
RS - Serbia 2
BG - Bulgaria 1
DK - Danimarca 1
IL - Israele 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SC - Seychelles 1
Totale 8.383
Città #
Dublin 1.358
Jacksonville 865
Dearborn 412
Chandler 286
Hong Kong 280
Wilmington 210
Lawrence 178
Princeton 178
Beijing 123
San Mateo 112
Ashburn 109
Ann Arbor 101
Singapore 99
Bremen 97
Andover 96
Dong Ket 48
Düsseldorf 47
Boardman 43
Monmouth Junction 43
Novara 40
Piemonte 40
Turin 35
Grafing 34
Leawood 33
Kunming 32
Milan 31
Ardabil 28
Brno 27
Norwalk 27
Woodbridge 26
Brussels 23
Torino 22
Houston 21
Vercelli 21
Seattle 20
Helsinki 19
Nanjing 19
Fairfield 17
Strasbourg 17
Toronto 16
Hefei 15
Bulandshahr 14
Philadelphia 14
Kocaeli 13
Zanjan 13
Augusta 11
Guangzhou 11
Jinan 11
Moncalieri 11
Munich 9
Fuzhou 8
Mülheim 8
Nichelino 8
Rome 8
Borgomanero 7
Hebei 7
Sacramento 7
Xian 7
Amsterdam 6
Cambridge 6
Cassano Magnago 6
Henderson 6
Menlo Park 6
Ottawa 6
Wuhan 6
Bari 5
Des Moines 5
Nanchang 5
Odalengo Grande 5
Canelli 4
Livorno Ferraris 4
New York 4
Polska 4
Shaoxing 4
Wenzhou 4
Zhengzhou 4
Alessandria 3
Bibbiano 3
Brescia 3
Frankfurt am Main 3
Harbin 3
Leipzig 3
Mumbai 3
Nocera Inferiore 3
Padova 3
San Diego 3
Sandrigo 3
São Paulo 3
Winnipeg 3
Americana 2
Baotou 2
Belgrade 2
Bologna 2
Bucharest 2
Buffalo 2
Carpenedolo 2
Casale Monferrato 2
Champigny-sur-marne 2
Chengdu 2
Chongqing 2
Totale 5.566
Nome #
Outcomes of music therapy interventions in cancer patients. A review of the literature 105
Evaluation of the short-term effects of dietary supplement “Flebotrofine” on markers of endothelial dysfunction in type 2 diabetes patients: a pilot study. 88
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or fibrosis 80
PREVALENCE OF AUTO-ANTIBODIES AGAINST CYTOCHROME P4502E1 IN ALCOHOLIC LIVER DISEASE 79
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis.Lipid 79
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection 77
A polymorphism in CTLA-4 is associated with the presence of anti-CYP2E1 antibody titres in patients with alcoholic liver disease 74
Usefulness of the platelet function analyzer PFA-100 in monitoring the efficacy of epoprostenol infusion 74
Cardiovascular Risk Profile of Patients Hospitalized for Myocardial Infarction is Undestimated by Traditional Risk Factors and is Better Estimated by a Genetic Analysis Based Upon Single Nucleotide Polymorphisms: A Retrospective Study 72
Lipid peroxidation promotes antibody formation in patients with alcoholic liver disease 69
ETHANOL FREE RADICAL AND LIVER DISEASE 69
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 68
Rischio genetico e rischio tradizionale in pazienti con sindrome coronarica acuta. 67
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 67
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 66
Genetic determinants of response to warfarin. 65
STRESS OSSIDATIVO ALCOL – INDOTTO IN PAZIENTI AFFETTI DA EPATITE CRONICA C 64
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 63
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 63
Un nuovo test genetico nella valutazione del rischio di cardiopatia ischemica? 63
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 62
An Observational Study of Venlafaxine and CYP2D6 in Clinical Practice. 61
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 61
Genetic determinants of response to warfarin. 61
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection 61
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 61
Anti-CYP2E1 auto-antibodies in alcoholic liver disease 60
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 60
La fosfolipasi A2 associata alle lipoproteine è un predittore indipendente di eventi cardiovascolari nei dializzati. 60
Oral microbiota and vitamin D impact on oropharyngeal squamous cell carcinogenesis: a narrative literature review 60
Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients 59
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 59
Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism. 58
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 58
An observational study of Venlafaxine and CYP2D6 in clinical practice. 58
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 57
Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients 56
Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe". 56
Rischio genetico e rischio tradizionale in pazienti con sindrome coronarica acuta. 56
Genetic polymorphism of Mn-SOD does not influences alcohol-induced oxidative stress and fibrosis 55
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 55
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 55
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 55
Screening for haemoglobin disorders: The experience of the piedmont north‐eastern quadrant 55
Apoptotic cells are the targets of anti-phospholipid antibodies associated with alcoholic liver disease 54
Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen 54
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 53
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 53
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 53
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 52
OXIDATIVE STRESS AS A TRIGGER FOR AUTOANTIBODY FORMATION DURING ALCOHOLIC LIVER DISEASE 51
Moderate alcohol intake increases oxidative stress in patients with chronic hepatitis C 51
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 51
Polymorphisms associated with increased cardiovascular risk in the general population do not predict acute events in hemodialysis patients 51
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 51
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 51
NEONATI A RISCHIO PER EMOGLOBINOPATIE: DIAGNOSI PRECOCE MEDIANTE SCREENING MIRATO A NOVARA 50
Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions. 50
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 50
Rischio genetico e rischio tradizionale in pazienti con sindrome coronarica acuta. 50
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 50
Malondialdehyde-Acetaldehyde (MAA) adducts trigger immune reactions in patients with alcoholic liver disease 49
APPROPRIATEZZA DELLA RICERCA DI INDAGINE MOLECOLARE PER IL FATTORE V DI LEIDEN 49
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 49
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 49
A proposed diagnostic approch to molecular pathophysiology of inherited disorders in haemoglobin synthesis 48
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 48
PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. 48
Immature platelet fraction and the extent of coronary artery disease: A single centre study 48
Genetic determinants of response to warfarin. 48
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 48
NEW INSITES IN THE BIOCHEMICAL MECHANISMS LEADING TO LIVER INJURY BY ALCOHOL 47
Apoptotic cells are the target of anti-phospholipid antibodies associated with alcoholic liver disease 47
Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity 47
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 47
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 47
Role of the laboratory in monitoring patients receiving dual antiplatelet therapy 47
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy 47
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 47
null 47
Similar anti-inflammatory effects of intracoronary and intravenous Abciximab during primary percutaneous coronary intervention: a randomized study. 46
Chronic hepatitis C and alcoholic-induced oxidative stress 45
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 45
OXIDATIVE DAMAGE STIMULATES IMMUNE REACTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE 44
Associazione aPTT normale e carenza fattoriale: criticità nella scelta dei reagenti 44
Screening delle emoglobinopatie 44
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 44
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. 44
Alcohol – induced oxidative stress contributes to development of immune reactions associated with alcoholic liver disease 44
Lipoprotein-associated phospholipase A2 predicts lower limb ischemia in hemodialysis subjects 44
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 44
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 44
Ruolo dello stress ossidativo nello sviluppo di reazioni immunitarie in corso di epatopatia alcolica 43
EFFETTO DELL’APLOTIPO HR2 SUL TEST PER APC-R PROC GLOBAL DELLA DADE-BEHRING 43
Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden 43
Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients 43
Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy 43
Effects of Probiotics Administration on Human Metabolic Phenotype 43
Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention 42
Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen 42
Totale 5.507
Categoria #
all - tutte 46.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.606 6 7 143 10 250 250 343 89 163 173 171 1
2020/20211.104 156 1 145 7 141 37 166 8 169 42 172 60
2021/20221.262 42 95 137 81 69 20 155 44 64 50 244 261
2022/20232.755 218 111 164 63 215 218 67 127 1.388 19 95 70
2023/20241.030 69 65 87 28 158 22 229 27 3 36 121 185
2024/202559 59 0 0 0 0 0 0 0 0 0 0 0
Totale 8.672